The District of Columbia Warrant Agreement of Immunomedics, Inc. is a legal agreement that outlines the terms and conditions for the purchase of shares of common stock in the company. This agreement is specific to the District of Columbia jurisdiction and ensures compliance with the local regulations and laws governing the purchase and ownership of securities. Under this agreement, Immunomedics, Inc. grants the warrant holder the right to purchase a specified number of shares of the company's common stock at a predetermined price within a specified time frame. The warrant agreement serves as a written contract between the company and the warrant holder, establishing the terms of the transaction and protecting the rights of both parties involved. The primary purpose of the District of Columbia Warrant Agreement is to provide an avenue for Immunomedics, Inc. to raise capital by issuing warrants and allowing investors to purchase shares at a future date. This arrangement enables the company to attract potential investors and expand its shareholder base while providing an opportunity for purchasers to potentially profit from possible future stock price appreciation. It is worth noting that there may be different types of District of Columbia Warrant Agreements of Immunomedics, Inc. to purchase shares of common stock. These variations could include terms such as the exercise price, expiration date of the warrant, the number of shares offered, and any additional provisions specific to each agreement. One example of a variation is a long-term warrant agreement, which grants the holder the right to purchase shares at a set price over an extended period. Another type could be a short-term warrant agreement, which has a shorter exercise window and a lower predetermined price, making it more attractive for investors seeking a quick return on investment. These different types of warrant agreements cater to various investment strategies and preferences within the District of Columbia jurisdiction. In summary, the District of Columbia Warrant Agreement of Immunomedics, Inc. is a legally binding document that allows investors to purchase shares of the company's common stock at a specified price within a specific time frame. These warrants help Immunomedics, Inc. raise capital and expand its shareholder base, while providing an opportunity for investors to potentially profit from future stock price appreciation.